Human Transfer RNA Modopathies: Diseases Caused by Aberrations in Transfer RNA Modifications

Overview

Journal FEBS J

Specialty Biochemistry

Date 2021 Jan 29

PMID 33513290

Citations 52

Authors

Takeshi Chujo

Kazuhito Tomizawa

Affiliations

Soon will be listed here.

Abstract

tRNA molecules are post-transcriptionally modified by tRNA modification enzymes. Although composed of different chemistries, more than 40 types of human tRNA modifications play pivotal roles in protein synthesis by regulating tRNA structure and stability as well as decoding genetic information on mRNA. Many tRNA modifications are conserved among all three kingdoms of life, and aberrations in various human tRNA modification enzymes cause life-threatening diseases. Here, we describe the class of diseases and disorders caused by aberrations in tRNA modifications as 'tRNA modopathies'. Aberrations in over 50 tRNA modification enzymes are associated with tRNA modopathies, which most frequently manifest as dysfunctions of the brain and/or kidney, mitochondrial diseases, and cancer. However, the molecular mechanisms that link aberrant tRNA modifications to human diseases are largely unknown. In this review, we provide a comprehensive compilation of human tRNA modification functions, tRNA modification enzyme genes, and tRNA modopathies, and we summarize the elucidated pathogenic mechanisms underlying several tRNA modopathies. We will also discuss important questions that need to be addressed in order to understand the molecular pathogenesis of tRNA modopathies.

Citing Articles

Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase.

Devarkar S, Budding C, Pathirage C, Kavoor A, Herbert C, Limbach P Nucleic Acids Res. 2025; 53(5).

PMID: 40036503 PMC: 11878792. DOI: 10.1093/nar/gkaf114.

HPLC Analysis of tRNA-Derived Nucleosides.

Chen X, Xu F Bio Protoc. 2025; 15(4):e5213.

PMID: 40028021 PMC: 11865832. DOI: 10.21769/BioProtoc.5213.

Mitochondrial translation regulates terminal erythroid differentiation by maintaining iron homeostasis.

Morishima T, Fakruddin M, Kanamori Y, Masuda T, Ogawa A, Wang Y Sci Adv. 2025; 11(8):eadu3011.

PMID: 39983002 PMC: 11844735. DOI: 10.1126/sciadv.adu3011.

TRMT1L-catalyzed mG27 on tyrosine tRNA is required for efficient mRNA translation and cell survival under oxidative stress.

Hwang S, Liao H, Barondeau K, Han X, Herbert C, McConie H Cell Rep. 2025; 44(1):115167.

PMID: 39786998 PMC: 11834103. DOI: 10.1016/j.celrep.2024.115167.

Human TRMT1 and TRMT1L paralogs ensure the proper modification state, stability, and function of tRNAs.

Zhang K, Manning A, Lentini J, Howard J, Dalwigk F, Maroofian R Cell Rep. 2025; 44(1):115092.

PMID: 39786990 PMC: 11831618. DOI: 10.1016/j.celrep.2024.115092.

References

Guan M, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P . Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet. 2006; 79(2):291-302. PMC: 1559489. DOI: 10.1086/506389. View

Lin H, Miyauchi K, Harada T, Okita R, Takeshita E, Komaki H . CO-sensitive tRNA modification associated with human mitochondrial disease. Nat Commun. 2018; 9(1):1875. PMC: 5951830. DOI: 10.1038/s41467-018-04250-4. View

Hawkins P, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr O . Evolving landscape in the management of transthyretin amyloidosis. Ann Med. 2015; 47(8):625-38. PMC: 4720049. DOI: 10.3109/07853890.2015.1068949. View

Goto Y, Nonaka I, Horai S . A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990; 348(6302):651-3. DOI: 10.1038/348651a0. View

Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner S . RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol. 2012; 19(9):900-5. DOI: 10.1038/nsmb.2357. View

Yeon S, Jo Y, Choi E, Kim M, Yoo N, Lee S . Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers. Pathol Oncol Res. 2017; 24(3):617-622. DOI: 10.1007/s12253-017-0287-2. View

Shaheen R, Han L, Faqeih E, Ewida N, Alobeid E, Phizicky E . A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum Genet. 2016; 135(7):707-13. PMC: 5152754. DOI: 10.1007/s00439-016-1665-7. View

Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D . Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2011; 51(11):916-22. DOI: 10.1002/mc.20861. View

Powell C, Kopajtich R, DSouza A, Rorbach J, Kremer L, Husain R . TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies. Am J Hum Genet. 2015; 97(2):319-28. PMC: 4573257. DOI: 10.1016/j.ajhg.2015.06.011. View

10.

Lorenz C, Lunse C, Morl M . tRNA Modifications: Impact on Structure and Thermal Adaptation. Biomolecules. 2017; 7(2). PMC: 5485724. DOI: 10.3390/biom7020035. View

11.

Kernohan K, Dyment D, Pupavac M, Cramer Z, McBride A, Bernard G . Matchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene. Hum Mutat. 2017; 38(5):511-516. DOI: 10.1002/humu.23196. View

12.

Pathak C, Jaiswal Y, Vinayak M . Hypomodification of transfer RNA in cancer with respect to queuosine. RNA Biol. 2006; 2(4):143-8. DOI: 10.4161/rna.2.4.2417. View

13.

Pagliarini D, Calvo S, Chang B, Sheth S, Vafai S, Ong S . A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008; 134(1):112-23. PMC: 2778844. DOI: 10.1016/j.cell.2008.06.016. View

14.

Noma A, Kirino Y, Ikeuchi Y, Suzuki T . Biosynthesis of wybutosine, a hyper-modified nucleoside in eukaryotic phenylalanine tRNA. EMBO J. 2006; 25(10):2142-54. PMC: 1462984. DOI: 10.1038/sj.emboj.7601105. View

15.

Gunduz U, Elliott M, Seubert P, HOUGHTON J, Houghton P, Trewyn R . Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line. Biochim Biophys Acta. 1992; 1139(3):229-38. DOI: 10.1016/0925-4439(92)90139-e. View

16.

Yarham J, Lamichhane T, Pyle A, Mattijssen S, Baruffini E, Bruni F . Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA. PLoS Genet. 2014; 10(6):e1004424. PMC: 4046958. DOI: 10.1371/journal.pgen.1004424. View

17.

Crick F . On protein synthesis. Symp Soc Exp Biol. 1958; 12:138-63. View

18.

Boland C, Hayes P, Santa-Maria I, Nishimura S, Kelly V . Queuosine formation in eukaryotic tRNA occurs via a mitochondria-localized heteromeric transglycosylase. J Biol Chem. 2009; 284(27):18218-27. PMC: 2709355. DOI: 10.1074/jbc.M109.002477. View

19.

Vangipurapu J, Stancakova A, Pihlajamaki J, Kuulasmaa T, Kuulasmaa T, Paananen J . Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men. Diabetologia. 2010; 54(3):563-71. DOI: 10.1007/s00125-010-1977-4. View

20.

Kato T, Daigo Y, Hayama S, Ishikawa N, Yamabuki T, Ito T . A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005; 65(13):5638-46. DOI: 10.1158/0008-5472.CAN-05-0600. View